BDSX
Biodesix, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$26.18
−1.11%Leverage
- Debt / equity
- 7.85x
- Net debt / equity
- 4.57x
- Debt / assets
- 0.75x
- Debt / EBITDA
- -5.03x
- Net debt / EBITDA
- -2.93x
Liquidity & coverage
- Current ratio
- 2.85x
- Quick ratio
- 2.85x
- Cash ratio
- 1.96x
- Interest coverage
- -2.54x
- EBITDA / interest
- -1.76x
- Working capital
- $28.3M
Cash & dividend
- FCF / debt
- -0.28x
- Cash flow / debt
- -0.28x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026